A July 2, 2016 article from Judith Graham looks at the recent wave of state Medicaid programs to increase access to Hepatitis C medications in the light of potential litigation from the Center for Health Law and Policy Innovation, its partners, and other organizations.
“Help with the high cost of hepatitis C drugs,” which ran in both USA Today and Kaiser Health News, looks at recent changes in access in Florida, New York, Delaware, Washington, and most recently, Massachusetts.
Excerpt from article:
“Costello’s (Kevin Costello, director of litigation at Harvard Law School’s Center for Health Law & Policy Innovation) center was a key player in the lawsuits in Washington state and Delaware and plans to bring similar actions elsewhere. ‘A 50 state solution is what we’re looking for,’ he said.”